Pfizer and Abbott, whose top cough syrup brands have been covered under the ban, have, however, already moved court against the government's action. Pfizer has secured interim relief from the Delhi High Court on March 14.
India's ministry of health and family welfare has already prohibited the manufacture, sale and distribution for human use 344 FDCs...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?